As a dominant non-receptor tyrosine kinase activated in HCC, abnormal sarcoma (Src) signaling activation conferred by HBV is involved in HBV-mediated HCC [49,50]. The gene discussed is NTRK1; the disease is hepatocellular carcinoma.